Robert A. Galemmo

LRRK2 secretion in exosomes is regulated by 14-3-3

K. B. Fraser, Mark S. Moehle, João Paulo Lima Daher et al. · Human Molecular Genetics · 2013 · 168 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Structure-Based Design of Novel Guanidine/Benzamidine Mimics:  Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants

Patrick Y. S. Lam, Charles G. Clark, Renhua Li et al. · Journal of Medicinal Chemistry · 2003 · 96 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-<i>N</i>- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1<i>H</i>-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

James R. Pruitt, Donald Pinto, Robert A. Galemmo et al. · Journal of Medicinal Chemistry · 2003 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Improved Solution- and Solid-Phase Preparation of Hydroxamic Acids from Esters

Chih Y. Ho, Eric D. Strobel, Janet L. Ralbovsky et al. · The Journal of Organic Chemistry · 2005 · 65 citations

Natural Sciences, Chemistry, Solid-state Chemistry +5

The synthesis and SAR of 2-amino-pyrrolo[2,3-d]pyrimidines: A new class of Aurora-A kinase inhibitors

K.J.M. Moriarty, Holly K. Koblish, Thomas Garrabrant et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +11